Compare Unichem Lab with ALEMBIC PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs ALEMBIC PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB ALEMBIC PHARMA UNICHEM LAB/
ALEMBIC PHARMA
 
P/E (TTM) x 91.8 15.9 578.5% View Chart
P/BV x 0.8 3.0 25.0% View Chart
Dividend Yield % 1.5 1.8 82.3%  

Financials

 UNICHEM LAB   ALEMBIC PHARMA
EQUITY SHARE DATA
    UNICHEM LAB
Mar-21
ALEMBIC PHARMA
Mar-21
UNICHEM LAB/
ALEMBIC PHARMA
5-Yr Chart
Click to enlarge
High Rs3601,150 31.3%   
Low Rs122527 23.1%   
Sales per share (Unadj.) Rs175.4274.4 63.9%  
Earnings per share (Unadj.) Rs4.956.7 8.7%  
Cash flow per share (Unadj.) Rs16.966.0 25.6%  
Dividends per share (Unadj.) Rs4.0014.00 28.6%  
Avg Dividend yield %1.71.7 99.5%  
Book value per share (Unadj.) Rs362.0260.9 138.8%  
Shares outstanding (eoy) m70.41196.56 35.8%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x1.43.1 44.9%   
Avg P/E ratio x48.914.8 330.8%  
P/CF ratio (eoy) x14.212.7 112.2%  
Price / Book Value ratio x0.73.2 20.7%  
Dividend payout %81.224.7 329.1%   
Avg Mkt Cap Rs m16,954164,818 10.3%   
No. of employees `000NANA-   
Total wages/salary Rs m3,07010,512 29.2%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m12,35153,931 22.9%  
Other income Rs m502875 57.4%   
Total revenues Rs m12,85354,806 23.5%   
Gross profit Rs m91114,801 6.2%  
Depreciation Rs m8441,835 46.0%   
Interest Rs m51160 32.0%   
Profit before tax Rs m51813,681 3.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1722,533 6.8%   
Profit after tax Rs m34711,148 3.1%  
Gross profit margin %7.427.4 26.9%  
Effective tax rate %33.118.5 178.8%   
Net profit margin %2.820.7 13.6%  
BALANCE SHEET DATA
Current assets Rs m13,77325,779 53.4%   
Current liabilities Rs m5,05812,808 39.5%   
Net working cap to sales %70.624.1 293.4%  
Current ratio x2.72.0 135.3%  
Inventory Days Days15523 657.9%  
Debtors Days Days74024 3,135.0%  
Net fixed assets Rs m17,34441,311 42.0%   
Share capital Rs m141393 35.8%   
"Free" reserves Rs m25,35050,883 49.8%   
Net worth Rs m25,49151,276 49.7%   
Long term debt Rs m01,999 0.0%   
Total assets Rs m31,11867,090 46.4%  
Interest coverage x11.186.4 12.9%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.40.8 49.4%   
Return on assets %1.316.9 7.6%  
Return on equity %1.421.7 6.3%  
Return on capital %2.226.0 8.6%  
Exports to sales %82.866.8 123.9%   
Imports to sales %14.412.7 113.6%   
Exports (fob) Rs m10,22436,020 28.4%   
Imports (cif) Rs m1,7806,845 26.0%   
Fx inflow Rs m10,22436,020 28.4%   
Fx outflow Rs m1,7806,845 26.0%   
Net fx Rs m8,44429,175 28.9%   
CASH FLOW
From Operations Rs m33114,634 2.3%  
From Investments Rs m-736-8,388 8.8%  
From Financial Activity Rs m-1,212-5,974 20.3%  
Net Cashflow Rs m-1,541262 -587.3%  

Share Holding

Indian Promoters % 50.1 69.0 72.6%  
Foreign collaborators % 0.0 0.5 -  
Indian inst/Mut Fund % 17.3 17.7 98.1%  
FIIs % 3.9 6.4 60.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 49.9 30.5 163.6%  
Shareholders   23,897 101,686 23.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   SANOFI INDIA  EVEREST ORGANICS  AURO LAB.  ABBOTT INDIA  PROCTER & GAMBLE HEALTH  



Today's Market

SGX Nifty Up 79 Points, 5 Factors Why Stock Markets Crashed, Dish TV's AGM, and Buzzing Stocks Today(Pre-Open)

Indian share markets ended deep in the red yesterday. Tracking a rout in the global markets, benchmark indices tumbled for the second day.

Related Views on News

ALEMBIC PHARMA 2020-21 Annual Report Analysis (Annual Result Update)

Jul 8, 2021 | Updated on Jul 8, 2021

Here's an analysis of the annual report of ALEMBIC PHARMA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of ALEMBIC PHARMA. Also includes updates on the valuation of ALEMBIC PHARMA.

ALEMBIC PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 13.8% (Quarterly Result Update)

Jan 19, 2021 | Updated on Jan 19, 2021

For the quarter ended December 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 13.8% YoY). Sales on the other hand came in at Rs 13 bn (up 8.7% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 30.0% (Quarterly Result Update)

Oct 23, 2020 | Updated on Oct 23, 2020

For the quarter ended September 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 30.0% YoY). Sales on the other hand came in at Rs 15 bn (up 17.4% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 33.3% (Quarterly Result Update)

Jan 23, 2020 | Updated on Jan 23, 2020

For the quarter ended December 2019, ALEMBIC PHARMA has posted a net profit of Rs 2 bn (up 33.3% YoY). Sales on the other hand came in at Rs 12 bn (up 18.8% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 25.2% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 25.2% YoY). Sales on the other hand came in at Rs 12 bn (up 10.1% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

More Views on News

Most Popular

Sansera Engineering IPO: Key Points to Consider(Views On News)

Sep 8, 2021

This IPO is a pure OFS and the company is looking to raise Rs 12.8 bn at the upper price band of Rs 744.

5 Indian Companies that are Leading the AI Race(Views On News)

Sep 9, 2021

During the pandemic, India reported the highest increase in the use of AI at 45% compared to other major economies. AI has potential to add US$90 bn to the Indian economy by 2025.

The Top Stocks to Sell in this Bull Market(Profit Hunter)

Sep 8, 2021

When I saw the list of so-called 'value stocks' published by a leading brokerage, my worst fears came true.

5 Specialty Chemical Stocks that Turned Multibaggers in One Year(Views On News)

Sep 17, 2021

These specialty chemical stocks have surged 200% or more in the last year. Do you own any?

How to Create a Second Income from Trading(Profit Hunter)

Sep 10, 2021

My trading system that works in all kinds of markets.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Sep 20, 2021 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 5-YR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS